Bessemer Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-165	Closed	-$1K	–	2742
2024 Q3	$1K	Buy	+165	New	+$1K	﹤0.01%	2596
2020 Q3	–	Sell	-63,300	Closed	-$1.55M	–	1719
2020 Q2	$1.55M	Buy	+63,300	New	+$1.55M	﹤0.01%	568